BillionToOne, Inc. (BLLN) short interest & options flow
NASDAQBLLN reports Q3 results today after the close. The genetic testing company, which makes cell-free DNA tests for prenatal screening and oncology, closed Tuesday at $113.89, up 7.5% over the past month but essentially flat on the week. Options positioning has shifted more defensive than at any point in recent memory. The put/call ratio reached 0.68 on Tuesday, more than two standard…
BLLN short interest surges 22.5% in one week to 2.98M shares, while availability plummets 39% to 169%—easier shorting conditions reversing sharply as stock rallies 11.3% weekly.
- Market cap
- $5.38B
- Next earnings
- 4 Mar 2027
Key data as of 8 Nov 2026
BLLN news and analysis
RSSNo long-form analysis yet for BLLN. Pulse alerts and the live data picture are available on ORTEX.
Open BLLN on ORTEX →Want the live picture for BLLN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BLLN — free to start on ORTEX.
Sign up for free →Open BLLN on ORTEX